User profiles for L. M. Poisson

Laila Marie Poisson

Henry Ford Health System
Verified email at hfhs.org
Cited by 22762

[HTML][HTML] The somatic genomic landscape of glioblastoma

…, PJ Park, J Seidman, L Yang, S Kalkanis, LM Poisson… - cell, 2013 - cell.com
We describe the landscape of somatic genomic alterations based on multidimensional and
comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify …

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

A Sreekumar, LM Poisson, TM Rajendiran, AP Khan… - Nature, 2009 - nature.com
Multiple, complex molecular events characterize cancer development and progression 1 , 2
. Deciphering the molecular networks that distinguish organ-confined disease from …

[PDF][PDF] An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics

J Liu, T Lichtenberg, KA Hoadley, LM Poisson… - Cell, 2018 - cell.com
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …

[HTML][HTML] “Omics” data and levels of evidence for biomarker discovery

D Ghosh, LM Poisson - Genomics, 2009 - Elsevier
With the development of new technologies for assaying biological activity on a global basis
in experimental samples, various new “-omics” signatures have been developed to predict …

[PDF][PDF] Glioma progression is shaped by genetic evolution and microenvironment interactions

…, T Weiss, M Weller, K Palucka, LF Stead, LM Poisson… - Cell, 2022 - cell.com
The factors driving therapy resistance in diffuse glioma remain poorly understood. To
identify treatment-associated cellular and genetic changes, we analyzed RNA and/or DNA …

Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas

…, D Bota, P Baldi, LM Poisson… - American Journal …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The World Health Organization has recently placed new
emphasis on the integration of genetic information for gliomas. While tissue sampling remains …

Longitudinal molecular trajectories of diffuse glioma in adults

…, J Noorbakhsh, DR Ormond, CK Park, LM Poisson… - Nature, 2019 - nature.com
The evolutionary processes that drive universal therapeutic resistance in adult patients with
diffuse glioma remain unclear 1 , 2 . Here we analysed temporally separated DNA-…

Estimating post-traumatic stress disorder in the community: lifetime perspective and the impact of typical traumatic events

N Breslau, EL Peterson, LM Poisson… - Psychological …, 2004 - cambridge.org
Background. Community surveys have assessed post-traumatic stress disorder (PTSD) in
relation to traumatic events designated by respondents as the worst they have ever …

T2–FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project

SH Patel, LM Poisson, DJ Brat, Y Zhou, L Cooper… - Clinical cancer …, 2017 - AACR
Purpose: Lower-grade gliomas (WHO grade II/III) have been classified into clinically
relevant molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to …

Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor

R Jain, LM Poisson, D Gutman, L Scarpace, SN Hwang… - Radiology, 2014 - pubs.rsna.org
Purpose To correlate patient survival with morphologic imaging features and hemodynamic
parameters obtained from the nonenhancing region (NER) of glioblastoma (GBM), along …